Strata Critical Medical, Inc. Class A Common Stock SRTA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.15M+162% | —— | $57.42M+3,038% | -$3.74M+67.0% | -$3.49M+17.5% | ||
| $3.06M+80.3% | $3.01M+96.6% | $1.7M+33.2% | $1.78M+13.9% | $1.7M+6.5% | ||
| $5.04M+19.4% | $6.59M+45.5% | $1.68M-68.9% | $5.35M-5.3% | $4.22M-2.3% | ||
| -$77K-353% | —— | $554K+569% | $21K— | -$17K+79.8% | ||
| -$344K— | —— | —— | —— | $0— | ||
| -$149K-129% | $3.48M— | $1.77M— | $6.26M+43.6% | $520K-80.1% | ||
| -$2.16M+5.3% | —— | $7.48M+1,022% | $3.19M— | -$2.28M+77.7% | ||
| -$78K-500% | $0-100% | -$592K-2,177% | -$61K+88.0% | -$13K-130% | ||
| $27K-71.0% | $83K-64.8% | $345K+316% | —— | $93K+3,000% | ||
| -$3K-100% | —— | —— | $999K-22.8% | $1.29M+11.5% | ||
| $3.89M+1,679% | -$8.31M-374% | -$37.3M— | -$3.06M— | -$246K+98.4% | ||
| $5.18M+98.1% | $1.85M-59.6% | $2.83M-69.6% | $2.3M-85.7% | $2.61M+220% | ||
| $30.5M-71.7% | —— | —— | $43.55M— | $107.75M+4.9% | ||
| $302K-43.2% | $157K-65.8% | $297K-50.8% | $429K-42.4% | $532K+71.1% | ||
| $0-100% | $0-100% | $49.86M-24.1% | $12.21M— | $84.2M+9.3% | ||
| $24.73M+21.2% | $18.27M— | $2.4M+119% | $28.68M— | $20.41M-16.9% | ||
| $52K-13.3% | $54K+22.7% | $65K+491% | $14K-36.4% | $60K-34.1% | ||
| $582K-86.5% | $1.8M-54.2% | $1.85M+150% | $1.15M+16.7% | $4.31M+11,538% | ||
| $329K— | —— | —— | —— | $0— | ||
| -$859K+79.8% | -$1.74M+55.0% | -$1.79M-144% | -$1.14M+5.9% | -$4.25M-7,963% | ||
| $0-100% | $0+100% | -$616K-1,094% | $151K+2,257% | $126K+585% | ||
| $27.76M+73.0% | $8.22M+567% | —— | $24.63M+354% | $16.04M+77.5% | ||
| $265K-63.3% | $482K-44.6% | $224K-72.8% | $785K-3.8% | $723K-51.2% | ||
| -$3.44M— | —— | —— | —— | $0— | ||
| -$344K— | —— | —— | —— | $0— | ||
| -$73K-343% | $0+100% | $29K+169% | $31K+147% | $30K+11.1% | ||
| -$383K+83.0% | $2.46M— | -$2.43M-3.1% | $3.9M+161% | -$2.25M-642% | ||
| —— | $11.08M— | $11.08M— | $11.08M— | $11.08M— | ||
| —— | $418.25K— | $418.25K— | $418.25K— | $418.25K— | ||
| $0-100% | $0-100% | $49.86M-24.1% | $12.21M— | $84.2M+9.3% | ||
| $302K-43.2% | $157K-65.8% | $297K-50.8% | $429K-42.4% | $532K+71.1% | ||
| $290K— | $1.57M— | —— | —— | $0— | ||
| $329K— | —— | —— | —— | $0— | ||
| $161K-52.5% | —— | $284K— | —— | $339K+18.9% | ||
| -$1.46M+47.0% | -$1.42M-145% | -$33K-111% | -$77K-108% | -$2.75M+20.9% | ||
| -$3K-100% | —— | —— | $999K-22.8% | $1.29M+11.5% | ||
| $1.32M+117% | $0— | $397K-81.8% | $592K-84.3% | $608K-76.4% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| -$1.29M+54.8% | -$10.16M-60.5% | -$40.13M-1,259% | -$5.37M+30.6% | -$2.86M+82.5% | ||
| -$1.29M+54.8% | -$10.16M-60.5% | -$40.13M-1,259% | -$5.37M+30.6% | -$2.86M+82.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Strata Critical Medical, Inc. Class A Common Stock generate?
- Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated -$44.8M in operating cash flow over the trailing twelve months.
- What is Strata Critical Medical, Inc. Class A Common Stock's free cash flow?
- After $12.2M of capital expenditures, Strata Critical Medical, Inc. Class A Common Stock's free cash flow was -$56.9M over the trailing twelve months, down 186.5% year over year.
- Where does Strata Critical Medical, Inc. Class A Common Stock's cash flow data come from?
- Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
